BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > South Korea > article

[Coronavirus] Two experimental anti-viral drugs to be tested as possible coronavirus treatments

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : March 3, 2020, 16:23 | Updated : March 4, 2020, 13:33
  • 트위터
  • 페이스북
  • 웨이보

[Gettyimages Bank]

SEOUL -- Two experimental anti-viral drugs will be tested to see if they are good for the treatment of patients infected with a novel coronavirus as health officials and medical staff complained about a shortage of beds and fatigue accumulation due to a spike in the number of confirmed cases.

The Ministry of Food and Drug Safety has approved clinical trials of remdesivir, an antiviral drug developed by Gilead Sciences, an American biotech company, and Virus Suppressing Factor (VSF) produced by ImmuneMed, a bio company in South Korea, as possible treatments for coronavirus infections.

VSF and remdesivir are still experimental, but the ministry decided to increase treatment options as there is no established cure or vaccine for illnesses caused by COVID-19. VSF, based on a naturally produced protein, is being developed to treat infections such as influenza, hepatitis B and C as well as incurable skin diseases.

Earlier, Food and Drug Safety Minister Lee Eui-kyung said he would consider importing Avigan, an anti-influenza drug produced by a unit of Japan's Fujifilm group. Japan has a stockpile of Avigan for about two million people to prepare for the outbreak of a new type of influenza.

South Korean doctors have formed a task force to find proper treatment by mixing antiviral drugs used to treat flu and HIV. Kaletra, an anti-retroviral medication used for AIDS treatment, was commonly applied, but doctors were not sure whether it played a crucial role in treating patients who have fully recovered.

As of Tuesday, the number of confirmed coronavirus patients has exceeded 5,100. The virus has killed 29 people, with 34 discharged from isolation wards. Health officials announced a change of priorities in detecting and treating patients in Daegu, the epicenter of South Korea's unabated epidemic.

"In fact, there are limits in many ways," Deputy Heal and Welfare Minister Kim Kang-rip told a regular pressing briefing, adding the level of fatigue was increasing among medical staff and support personnel in Daegu. "I think there is a need to expand the inspection of ordinary Daegu citizens more than Shincheonji believers."

Shincheonji Church of Jesus has been blamed for causing a sudden spike in the number of patients, since a 61-year-old follower was guaranteed on February 17 after attending services at its branch in Daegu where 2,685 Shincheonji followers and 1,300 ordinary citizens have been infected with COVID-19.

"The entire nation has entered a war against infectious diseases," President Moon Jae-in said in a video cabinet conference. "The crisis in Daegu and North Gyeongsang Province reached its peak."

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Anti-epidemic center warns of silent community infection by young untraceable virus carriers.
    Anti-epidemic center warns of silent community infection by …
  • .Samsung, Kakao and SKT join hands to jointly develop AI to tackle COVID-19 pandemic.
    Samsung, Kakao and SKT join hands to jointly develop AI to t…
  • .Moon visits announces potential deal with Novavax for 20 mln people: Yonhap.
    Moon visits announces potential deal with Novavax for 20 mln…
  • .S. Korea earns $2.27 billion with exports of in-vitro diagnostic devices.
    S. Korea earns $2.27 billion with exports of in-vitro diagno…
  • .SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 .
    SK Bioscience embarks on clinical test of COVID-19 vaccine c…

Real Time Photo News

  • .NCSofts global K-pop fan community platform to service original content including songs.

    NCSoft's global K-pop fan community platform to service original content including songs

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

  • .Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series Criminal Justice.

    Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series 'Criminal Justice'

Latest News

more+

  • Former coach gets jail term of over 10 years for sexually assaulting Olympic gold medalist
  • S. Korea demonstrates 20-minute ultra-fast EV chargers in southern resort island
  • Innovative electric vehicle charging station makes debut in Seoul as lifestyle complex
  • SK Innovation makes strategic investment in China's battery service company
  • Daewoo shipyard's SOFC ship certified by American classification society
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view